ALTSCHULLER Susan
Insider CIK 1817988 · CLYM Chief Financial Officer · CERE Chief Financial Officer · MURA Director · IMGN SVP and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLYM Climb Bio, Inc. | A Award deriv | 2026-01-06 | 2026-01-08 | 142,500 | — | $0 | 142,500 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-10-01 | 2025-10-01 | 600,000 | — | $0 | 600,000 | SEC↗ |
| MURA Mural Oncology plc | P Buy | 2024-08-14 | 2024-08-15 | 10,000 | $3.21 | $32.1K | 10,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 124,168 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 81,065 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 16,913 | — | $0 | 0 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2024-05-30 | 2024-06-03 | 8,462 | $3.35 | $28.3K | 8,462 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2024-05-30 | 2024-06-05 | 8,462 | — | $0 | 8,462 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2024-01-19 | 2024-01-23 | 81,065 | — | $0 | 81,065 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-12-20 | 2023-12-21 | 13,808 | $41.42 | $571.9K | 16,913 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-19 | 2023-12-21 | 30,721 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-19 | 2023-12-21 | 30,721 | — | $0 | 30,721 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2023-12-14 | 2023-12-18 | 15,021 | — | $0 | 15,021 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-06-01 | 2023-06-05 | 124,168 | — | $0 | 124,168 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-06-01 | 2023-06-05 | 30,721 | — | $0 | 30,721 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-11-14 | 2022-12-27 | 82,500 | — | $0 | 123,750 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-05-20 | 2022-12-27 | 41,250 | — | $0 | 41,250 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-02-04 | 2022-02-08 | 361,568 | $5.32 | $1.92M | 361,568 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-02-05 | 2021-02-09 | 163,798 | $7.69 | $1.26M | 163,798 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2020-07-20 | 2020-07-22 | 300,000 | $4.74 | $1.42M | 300,000 | SEC↗ |